TSX closed
Loading marketsโ€ฆ

Advertisement

Stocks

What's Going On With Crombie Real Estate Investment Trust Stock Tuesday?

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:CRR-UN.TO

Get CRR-UN alerts:

Photos provided by Pexels

Crombie Real Estate Investment Trust's stock has seen a slight decline this week, despite positive operational results announced earlier.

Crombie Real Estate Investment Trust (CRR-UN.TO) closed at C$15.96, down 0.43% today and down 1.75% over the past week. While the stock has faced some downward pressure recently, the company has reported solid operational results that may indicate underlying strength.

Investor takeaway: Crombie REIT's recent performance highlights its operational efficiency and commitment to unitholder returns, but current market conditions have led to a slight decrease in stock price. Investors should weigh the company's strong fundamentals against market trends.

Advertisement

Crombie Real Estate Investment Trust

CRR-UN.TO

Full stock page โ†’

CRR-UN.TO

Crombie Real Estate Investment Trust

Source:WealthAwesomeWealthAwesome
โ†‘ $0.30 (1.88%)
120 day period
$15.57$16.72$17.87Mar 11Jun 5Aug 31

Market cap

$3.07B

Div. yield

5.46%

Div. / share

$0.90

52W high

$17.76

52W low

$13.93

1W change

-1.75%

Beta

0.91

Analyst Price Targets

Based on analyst covering CRR-UN

๐Ÿ“ˆ

Wall Street analysts forecast CRR-UN stock price to rise 14.1% over the next 12 months.

Consensus

Moderately Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$18.57

+14.1% Upside

Current Price

C$16.28

Last close

Compare analyst targets across the TSX & TSXV โ†’

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on CRR-UN's historical volatility

HistoricalForecast68%95%
C$12.51C$13.78C$15.06C$16.34C$17.62C$18.89TodayApr 23Jun 26Aug 31Oct 13Nov 26Jan 8

30-Day Vol

14.7%

Annualized

90-Day Vol

14.3%

Annualized

Trend (90d)

-15.9%

Annualized drift

90d Mean

C$15.38

Expected price

HorizonExpected68% Range (1ฯƒ)
30 trading daysC$15.97C$15.18 โ€“ C$16.81
60 trading daysC$15.67C$14.59 โ€“ C$16.84
90 trading daysC$15.38C$14.08 โ€“ C$16.80

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯƒ, 95% band = ยฑ2ฯƒ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Crombie REIT's stock is currently down 1.75% week-to-date.

The stock's recent performance contrasts with its positive operational results, reflecting potential market concerns despite strong fundamentals.

Bull case

Crombie's first-quarter results for 2026 show a 3.7% increase in commercial same-asset property cash NOI and a distribution increase. This suggests effective management and operational excellence, which could support future growth.

Bear case

Despite the positive operational results, the stock has underperformed recently, trading below both its 50-day and 200-day moving averages. This trend may signal caution for investors as they consider current market conditions.

Recent Price Action

Advertisement

Crombie REIT's stock closed at C$15.96, reflecting a decrease of 0.43% today and a decline of 1.75% over the past week. The stock is down 6.81% over the last month but has shown a year-to-date increase of 6.13%, suggesting some resilience in a challenging market.

Company News

Crombie recently announced its first-quarter results for 2026, highlighting a 3.7% growth in commercial same-asset property cash NOI and an increase in distributions. This performance underscores Crombie's operational excellence and disciplined capital allocation, which may provide a buffer against market fluctuations.

Technical Picture

Crombie's stock is currently trading below both its 50-day moving average of C$17.25 and its 200-day moving average of C$16.38, indicating a bearish trend in the short to medium term. The stock has a beta of 0.91, suggesting lower volatility compared to the broader market. The 52-week range for CRR-UN.TO is C$13.93 to C$17.76, with the current price at approximately 53% of that range. The latest trading volume was 363,802 shares, significantly above the 20-day average volume of 223,727 shares, indicating increased investor interest.

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile โ†’

โœ… Reviewed by Certified Financial Professionals

This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

๐Ÿ“Š Data AccuracyVerified sources
๐Ÿ‡จ๐Ÿ‡ฆ Canadian FocusLocal expertise
๐Ÿ” Fact-CheckedEditorial review

โš ๏ธ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: September 2, 2026
Last Updated: September 2, 2026
PARTNER SPOTLIGHT

Blue Cross Lifeยฎ Term Life Insurance

Affordable term life coverage in Canada โ€” get a free quote in seconds, no credit card required.

  • โœ“Coverage from $100,000 to $5 million, terms of 10โ€“30 years
  • โœ“10% off first-year premiums when couples apply together
  • โœ“Fully digital application โ€” many qualify without a medical exam

Sponsored links

Advertisement